Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1980 1
1986 1
1995 1
2000 1
2001 6
2002 2
2003 2
2004 1
2005 2
2006 1
2007 5
2008 5
2009 2
2010 6
2011 6
2012 7
2013 3
2014 8
2015 6
2016 2
2018 5
2019 3
2020 8
2021 7
2022 3
2023 4
2024 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell-like Type: Phase II Clinical Trial of the Spanish GELTAMO Group.
Rey-Búa B, Grande C, Sánchez Blanco JJ, Abrisqueta P, Gutiérrez A, Ramírez Páyer Á, Giné E, Zeberio Etxetxipia I, Terol MJ, de la Cruz Vicente F, Andreu R, Ramirez MJ, de la Fuente A, Viguria MC, Peñarrubia MJ, Jiménez-Ubieto A, Montes-Moreno S, López-Guillermo A, Caballero MD, Martín García-Sancho A. Rey-Búa B, et al. Among authors: andreu r. Clin Cancer Res. 2024 Sep 3;30(17):3704-3714. doi: 10.1158/1078-0432.CCR-24-0183. Clin Cancer Res. 2024. PMID: 38900037 Clinical Trial.
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Martín A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, Andreu R, Salar A, García-Sanchez P, Vázquez L, Nistal S, Requena MJ, Donato EM, González JA, León A, Ruiz C, Grande C, González-Barca E, Caballero MD; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group). Martín A, et al. Among authors: andreu r. Haematologica. 2008 Dec;93(12):1829-36. doi: 10.3324/haematol.13440. Epub 2008 Oct 22. Haematologica. 2008. PMID: 18945747 Free article.
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC).
Abrisqueta P, González-Barca E, Ferrà C, Ríos-Herranz E, Fernández de la Mata M, Delgado J, Andreu R, Hernández-Rivas JÁ, Terol MJ, Navarro A, Vidriales MB, Baltasar P, De la Serna J, Ramírez Á, Ballester C, Moreno C, García-Marco JA, Córdoba R, Yáñez L, Casado LF, González M, Bosch F. Abrisqueta P, et al. Among authors: andreu r. EClinicalMedicine. 2024 May 25;73:102642. doi: 10.1016/j.eclinm.2024.102642. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 38841711 Free PMC article.
Immunobiology of cytomegalovirus infection in patients with haematological malignancies undergoing treatment with small molecule inhibitors.
de la Asunción Carlos S, Giménez E, Hernández-Boluda JC, Terol MJ, Albert E, López-Jiménez J, García-Gutiérrez V, Andreu R, García D, Fox ML, Remigia MJ, Amat P, Solano C, Navarro D. de la Asunción Carlos S, et al. Among authors: andreu r. Br J Haematol. 2023 Mar;200(6):e58-e61. doi: 10.1111/bjh.18655. Epub 2023 Jan 18. Br J Haematol. 2023. PMID: 36652997 No abstract available.
Electric field-induced functional changes in electrode-immobilized mutant species of human cytochrome c.
Olloqui-Sariego JL, Pérez-Mejías G, Márquez I, Guerra-Castellano A, Calvente JJ, De la Rosa MA, Andreu R, Díaz-Moreno I. Olloqui-Sariego JL, et al. Among authors: andreu r. Biochim Biophys Acta Bioenerg. 2022 Oct 1;1863(7):148570. doi: 10.1016/j.bbabio.2022.148570. Epub 2022 May 25. Biochim Biophys Acta Bioenerg. 2022. PMID: 35643148 Free article.
Cytomegalovirus-specific T-cell immunity and DNAemia in patients with chronic lymphocytic leukaemia undergoing treatment with ibrutinib.
Solano de la Asunción C, Terol MJ, Saus A, Olea B, Giménez E, Albert E, López-Jiménez J, Andreu R, García D, Fox L, Remigia MJ, Amat P, Solano C, Navarro D. Solano de la Asunción C, et al. Among authors: andreu r. Br J Haematol. 2021 Nov;195(4):637-641. doi: 10.1111/bjh.17732. Epub 2021 Aug 16. Br J Haematol. 2021. PMID: 34402042 No abstract available.
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, Beneyto I, Espí J, Gómez-Codina J, Iacoboni G, Jarque I, López-Andújar R, Mayordomo-Aranda E, Montalar J, Pastor A, Pastor M, Piñana JL, Rojas-Ferrer N, Sánchez-Lázaro I, Sandoval J, Sanz G, Sanz MÁ, Solé A, Sanz J. Romero S, et al. Among authors: andreu r. Leuk Lymphoma. 2019 Jan;60(1):142-150. doi: 10.1080/10428194.2018.1474462. Epub 2018 Jul 3. Leuk Lymphoma. 2019. PMID: 29966464
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
Ródenas-Quiñonero I, Chen-Liang T, Martín-Santos T, Salar A, Fernández-González M, Celades C, Navarro JT, Martínez-Garcia AB, Andreu R, Balaguer A, Martin García-Sancho A, Baile M, López-Jiménez J, Marquet-Palomanes J, Teruel AI, Terol MJ, Benet C, Frutos L, Navarro JL, Uña J, Suarez M, Cortes M, Contreras J, Ruiz C, Tamayo P, Mucientes J, Sopena-Novales P, Reguilón-Gallego L, Sánchez-Blanco JJ, Pérez-Ceballos E, Jerez A, Ortuño FJ. Ródenas-Quiñonero I, et al. Among authors: andreu r. Cancer Med. 2023 Mar;12(6):6536-6546. doi: 10.1002/cam4.5424. Epub 2022 Nov 13. Cancer Med. 2023. PMID: 36373169 Free PMC article.
90 results